WHO considers Madagascar’s COVID Organics for clinical observation

The World Health Organisation (WHO) is considering Madagascar’s COVID Organics for clinical observation process.

The President of Madagascar, Andry Rajoelina made this known on Wednesday, saying that he and the Director-General of WHO, Tedros Ghebreyesus, had a successful interaction on COVID Organics.

In a tweet, President Rajoelina said, “Successful exchange with @DrTedros who commends #Madagascar’s efforts in the fight against #Covid19 and congratulates us for the discovery of #CovidOrganics.

@WHO will sign a confidentiality clause on its formulation and will support the clinical observations process in #Africa.

Following @WHO’s invitation to be part of « Solidarity Trial » for clinical trials, #Madagascar will prove the effectiveness of its third protocol that combinates two injectable medicines that are different from #CovidOrganics.

COVID Organics has been touted to be an effective medicine for the treatment of the novel coronavirus.